These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2785850)

  • 21. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.
    Delius M; Adams G
    Cancer Res; 1999 Oct; 59(20):5227-32. PubMed ID: 10537301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia.
    Bolognesi A; Polito L; Farini V; Bortolotti M; Tazzari PL; Ratta M; Ravaioli A; Horenstein AL; Stirpe F; Battelli MG; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):145-52. PubMed ID: 16602630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
    Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
    Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
    Flavell DJ; Warnes S; Noss A; Flavell SU
    Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunotoxin made up with campath 1 and saporin 6: preliminary "in vitro" experience.
    Gobbi M; Barbieri L; Tazzari PL; Dinota A; Bontadini A; Rizzi S; Pession A; Stirpe F; Tura S
    J Exp Pathol; 1987; 3(4):359-62. PubMed ID: 3331647
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
    Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
    Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
    Kreitman RJ; Margulies I; Stetler-Stevenson M; Wang QC; FitzGerald DJ; Pastan I
    Clin Cancer Res; 2000 Apr; 6(4):1476-87. PubMed ID: 10778980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
    Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
    Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia.
    Fournier S; Jackson J; Kumar A; King T; Sharma S; Biron G; Rubio M; Delespesse G; Sarfati M
    Eur J Immunol; 1992 Jul; 22(7):1927-30. PubMed ID: 1623931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local infusion of FGF-saporin reduces intimal hyperplasia.
    Mattar SG; Hanson SR; Pierce GF; Chen C; Hughes JD; Cook JE; Shen C; Noe BA; Suwyn CR; Scott JR; Lumsden AB
    J Surg Res; 1996 Feb; 60(2):339-44. PubMed ID: 8598665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin.
    Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F
    Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
    Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
    Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C3b receptors mediate the growth factor-induced proliferation of malignant B-chronic lymphocytic leukemia lymphocytes.
    Caligaris-Cappio F; Schena M; Bergui L; Tesio L; Riva M; Rege-Cambrin G; Funaro A; Malavasi F
    Leukemia; 1987 Nov; 1(11):746-52. PubMed ID: 2960860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different sensitivity of CD30+ cell lines to Ber-H2/saporin-S6 immunotoxin.
    Battelli MG; Bolognesi A; Olivieri F; Polito L; Stirpe F
    J Drug Target; 1998; 5(3):181-91. PubMed ID: 9606008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative effect of basic fibroblast growth factor-saporin mitotoxin on keratocytes in culture.
    Wee WR; Parandoosh Z; Sakamoto T; Caton M; Nova M; McDonnell PJ
    Korean J Ophthalmol; 1996 Jun; 10(1):1-7. PubMed ID: 8755195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
    Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
    Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-thecal treatment of leptomeningeal lymphoma with immunotoxin.
    Urch CE; George AJ; Stevenson GT; Bolognesi A; Stirpe F; Weller R; Glennie MJ
    Int J Cancer; 1991 Apr; 47(6):909-15. PubMed ID: 2010234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.